Research Paper Volume 15, Issue 20 pp 11588—11610
Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma
Figure 9. Immunotherapy analysis. (A, B) Gene expression of immune checkpoint molecules and pyroptosis-related genes in high- and low-risk groups. (C) GSVA analysis telling which functions or pathways were active in high- and low-risk groups with * indicated correlation, green indicated negative correlation, and red indicated positive correlation. (D–G) Immunotherapy analysis to compare the effect of immunotherapy in high- and low-risk groups. (H–K) Drug sensitivity analysis of various drugs differences between high- and low-risk groups with p-value < 0.05 indicating a difference.